CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Value Chain Analysis
3.8.Regulatory Guidelines
3.9.Market Share Analysis
3.10.Key Regulation Analysis
3.11.Patent Landscape
CHAPTER 4: WORLD ALLERGY DIAGNOSTIC MARKET, BY TEST TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 In Vivo
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 In Vitro
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: WORLD ALLERGY DIAGNOSTIC MARKET, BY PRODUCT & SERVICE
5.1 Overview
5.1.1 Market size and forecast
5.2 Consumables
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Instruments
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Services
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: WORLD ALLERGY DIAGNOSTIC MARKET, BY ALLERGEN
6.1 Overview
6.1.1 Market size and forecast
6.2 Inhaled Allergens
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Food Allergens
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Drug Allergens
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Other Allergens
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: WORLD ALLERGY DIAGNOSTIC MARKET, BY END-USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Diagnostic Laboratories
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Hospital-based Laboratories
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Academic Research Institutes
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: WORLD ALLERGY DIAGNOSTIC MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Test Type
8.2.3 North America Market size and forecast, by Product & Service
8.2.4 North America Market size and forecast, by Allergen
8.2.5 North America Market size and forecast, by End-user
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Test Type
8.2.6.1.2 Market size and forecast, by Product & Service
8.2.6.1.3 Market size and forecast, by Allergen
8.2.6.1.4 Market size and forecast, by End-user
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Test Type
8.2.6.2.2 Market size and forecast, by Product & Service
8.2.6.2.3 Market size and forecast, by Allergen
8.2.6.2.4 Market size and forecast, by End-user
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Test Type
8.2.6.3.2 Market size and forecast, by Product & Service
8.2.6.3.3 Market size and forecast, by Allergen
8.2.6.3.4 Market size and forecast, by End-user
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Test Type
8.3.3 Europe Market size and forecast, by Product & Service
8.3.4 Europe Market size and forecast, by Allergen
8.3.5 Europe Market size and forecast, by End-user
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Test Type
8.3.6.1.2 Market size and forecast, by Product & Service
8.3.6.1.3 Market size and forecast, by Allergen
8.3.6.1.4 Market size and forecast, by End-user
8.3.6.2 UK
8.3.6.2.1 Market size and forecast, by Test Type
8.3.6.2.2 Market size and forecast, by Product & Service
8.3.6.2.3 Market size and forecast, by Allergen
8.3.6.2.4 Market size and forecast, by End-user
8.3.6.3 France
8.3.6.3.1 Market size and forecast, by Test Type
8.3.6.3.2 Market size and forecast, by Product & Service
8.3.6.3.3 Market size and forecast, by Allergen
8.3.6.3.4 Market size and forecast, by End-user
8.3.6.4 Spain
8.3.6.4.1 Market size and forecast, by Test Type
8.3.6.4.2 Market size and forecast, by Product & Service
8.3.6.4.3 Market size and forecast, by Allergen
8.3.6.4.4 Market size and forecast, by End-user
8.3.6.5 Italy
8.3.6.5.1 Market size and forecast, by Test Type
8.3.6.5.2 Market size and forecast, by Product & Service
8.3.6.5.3 Market size and forecast, by Allergen
8.3.6.5.4 Market size and forecast, by End-user
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Test Type
8.3.6.6.2 Market size and forecast, by Product & Service
8.3.6.6.3 Market size and forecast, by Allergen
8.3.6.6.4 Market size and forecast, by End-user
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Test Type
8.4.3 Asia-Pacific Market size and forecast, by Product & Service
8.4.4 Asia-Pacific Market size and forecast, by Allergen
8.4.5 Asia-Pacific Market size and forecast, by End-user
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 China
8.4.6.1.1 Market size and forecast, by Test Type
8.4.6.1.2 Market size and forecast, by Product & Service
8.4.6.1.3 Market size and forecast, by Allergen
8.4.6.1.4 Market size and forecast, by End-user
8.4.6.2 Japan
8.4.6.2.1 Market size and forecast, by Test Type
8.4.6.2.2 Market size and forecast, by Product & Service
8.4.6.2.3 Market size and forecast, by Allergen
8.4.6.2.4 Market size and forecast, by End-user
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Test Type
8.4.6.3.2 Market size and forecast, by Product & Service
8.4.6.3.3 Market size and forecast, by Allergen
8.4.6.3.4 Market size and forecast, by End-user
8.4.6.4 South Korea
8.4.6.4.1 Market size and forecast, by Test Type
8.4.6.4.2 Market size and forecast, by Product & Service
8.4.6.4.3 Market size and forecast, by Allergen
8.4.6.4.4 Market size and forecast, by End-user
8.4.6.5 Australia
8.4.6.5.1 Market size and forecast, by Test Type
8.4.6.5.2 Market size and forecast, by Product & Service
8.4.6.5.3 Market size and forecast, by Allergen
8.4.6.5.4 Market size and forecast, by End-user
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Test Type
8.4.6.6.2 Market size and forecast, by Product & Service
8.4.6.6.3 Market size and forecast, by Allergen
8.4.6.6.4 Market size and forecast, by End-user
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Test Type
8.5.3 LAMEA Market size and forecast, by Product & Service
8.5.4 LAMEA Market size and forecast, by Allergen
8.5.5 LAMEA Market size and forecast, by End-user
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Test Type
8.5.6.1.2 Market size and forecast, by Product & Service
8.5.6.1.3 Market size and forecast, by Allergen
8.5.6.1.4 Market size and forecast, by End-user
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Test Type
8.5.6.2.2 Market size and forecast, by Product & Service
8.5.6.2.3 Market size and forecast, by Allergen
8.5.6.2.4 Market size and forecast, by End-user
8.5.6.3 United Arab Emirates
8.5.6.3.1 Market size and forecast, by Test Type
8.5.6.3.2 Market size and forecast, by Product & Service
8.5.6.3.3 Market size and forecast, by Allergen
8.5.6.3.4 Market size and forecast, by End-user
8.5.6.4 South Africa
8.5.6.4.1 Market size and forecast, by Test Type
8.5.6.4.2 Market size and forecast, by Product & Service
8.5.6.4.3 Market size and forecast, by Allergen
8.5.6.4.4 Market size and forecast, by End-user
8.5.6.5 Rest of LAMEA
8.5.6.5.1 Market size and forecast, by Test Type
8.5.6.5.2 Market size and forecast, by Product & Service
8.5.6.5.3 Market size and forecast, by Allergen
8.5.6.5.4 Market size and forecast, by End-user
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Alerchek Inc.
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 Danaher Corp
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Hitachi chemical Diagnostic Inc.
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 HOB Biotech Group Co. Ltd.
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Hycor Biomedical Inc.
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Lincoln Diagnostics Inc.
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Omega Diagnostic Llc
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Siemens Healthcare Diagnostics, Inc.
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Stallergenes SA
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Thermo Fisher Scientific Inc.
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 Thermo Fisher Scientific Inc.
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 Danaher
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 Omega Diagnostics Group PLC
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 Eurofins Scientific
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15 bioMérieux SA
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments
10.16 HollisterStier Allergy
10.16.1 Company overview
10.16.2 Company snapshot
10.16.3 Operating business segments
10.16.4 Product portfolio
10.16.5 Business performance
10.16.6 Key strategic moves and developments
10.17 Minaris Medical America, Inc.
10.17.1 Company overview
10.17.2 Company snapshot
10.17.3 Operating business segments
10.17.4 Product portfolio
10.17.5 Business performance
10.17.6 Key strategic moves and developments
10.18 ACON Laboratories, Inc.
10.18.1 Company overview
10.18.2 Company snapshot
10.18.3 Operating business segments
10.18.4 Product portfolio
10.18.5 Business performance
10.18.6 Key strategic moves and developments
10.19 Lincoln Diagnostics, Inc.
10.19.1 Company overview
10.19.2 Company snapshot
10.19.3 Operating business segments
10.19.4 Product portfolio
10.19.5 Business performance
10.19.6 Key strategic moves and developments
10.20 Neogen Corporation
10.20.1 Company overview
10.20.2 Company snapshot
10.20.3 Operating business segments
10.20.4 Product portfolio
10.20.5 Business performance
10.20.6 Key strategic moves and developments
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
